Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 19197165)

1.

Hypofractionation for prostate cancer.

Ritter M, Forman J, Kupelian P, Lawton C, Petereit D.

Cancer J. 2009 Jan-Feb;15(1):1-6. doi: 10.1097/PPO.0b013e3181976614.

2.
3.

Rationale, conduct, and outcome using hypofractionated radiotherapy in prostate cancer.

Ritter M.

Semin Radiat Oncol. 2008 Oct;18(4):249-56. doi: 10.1016/j.semradonc.2008.04.007.

4.

What hypofractionated protocols should be tested for prostate cancer?

Fowler JF, Ritter MA, Chappell RJ, Brenner DJ.

Int J Radiat Oncol Biol Phys. 2003 Jul 15;56(4):1093-104.

PMID:
12829147
5.

Is the alpha/beta value for prostate tumours low enough to be safely used in clinical trials?

Daşu A.

Clin Oncol (R Coll Radiol). 2007 Jun;19(5):289-301. Epub 2007 Mar 9. Review.

PMID:
17517328
6.

Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue.

Brenner DJ, Martinez AA, Edmundson GK, Mitchell C, Thames HD, Armour EP.

Int J Radiat Oncol Biol Phys. 2002 Jan 1;52(1):6-13.

PMID:
11777617
7.

Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: α/β = 1.4 (0.9-2.2) Gy.

Miralbell R, Roberts SA, Zubizarreta E, Hendry JH.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):e17-24. doi: 10.1016/j.ijrobp.2010.10.075. Epub 2011 Feb 15.

PMID:
21324610
8.

Whole-pelvic nodal radiation therapy in the context of hypofractionation for high-risk prostate cancer patients: a step forward.

Kaidar-Person O, Roach M 3rd, Créhange G.

Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):600-5. doi: 10.1016/j.ijrobp.2013.02.006. Epub 2013 Mar 20. Review.

PMID:
23523182
9.
10.

Fractionation and protraction for radiotherapy of prostate carcinoma.

Brenner DJ, Hall EJ.

Int J Radiat Oncol Biol Phys. 1999 Mar 15;43(5):1095-101.

PMID:
10192361
11.

The low alpha/beta ratio for prostate cancer: what does the clinical outcome of HDR brachytherapy tell us?

Wang JZ, Li XA, Yu CX, DiBiase SJ.

Int J Radiat Oncol Biol Phys. 2003 Nov 15;57(4):1101-8.

PMID:
14575842
12.
13.

High-dose-rate monotherapy: safe and effective brachytherapy for patients with localized prostate cancer.

Demanes DJ, Martinez AA, Ghilezan M, Hill DR, Schour L, Brandt D, Gustafson G.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1286-92. doi: 10.1016/j.ijrobp.2010.10.015. Epub 2011 Feb 9.

PMID:
21310546
14.

The emerging role of high-dose-rate (HDR) brachytherapy as monotherapy for prostate cancer.

Yoshioka Y, Yoshida K, Yamazaki H, Nonomura N, Ogawa K.

J Radiat Res. 2013 Sep;54(5):781-8. doi: 10.1093/jrr/rrt027. Epub 2013 Mar 29. Review.

15.

Extreme hypofractionation for prostate cancer.

Lee WR.

Expert Rev Anticancer Ther. 2009 Jan;9(1):61-5. doi: 10.1586/14737140.9.1.61.

PMID:
19105707
16.

Systematic review of hypofractionated radiation therapy for prostate cancer.

Zaorsky NG, Ohri N, Showalter TN, Dicker AP, Den RB.

Cancer Treat Rev. 2013 Nov;39(7):728-36. doi: 10.1016/j.ctrv.2013.01.008. Epub 2013 Mar 1. Review.

17.

[Alpha/beta ratio revisited in the era of hypofractionation].

Hennequin C, Dubray B.

Cancer Radiother. 2013 Oct;17(5-6):344-8. doi: 10.1016/j.canrad.2013.06.035. Epub 2013 Aug 22. Review. French.

PMID:
23972468
18.

Radiotherapeutic techniques for prostate cancer, dose escalation and brachytherapy.

Khoo VS.

Clin Oncol (R Coll Radiol). 2005 Oct;17(7):560-71. Review.

PMID:
16238144
19.

High dose-rate afterloading 192Iridium prostate brachytherapy: feasibility report.

Mate TP, Gottesman JE, Hatton J, Gribble M, Van Hollebeke L.

Int J Radiat Oncol Biol Phys. 1998 Jun 1;41(3):525-33.

PMID:
9635698
20.

Hypofractionation: what does it mean for prostate cancer treatment?

Liao Y, Joiner M, Huang Y, Burmeister J.

Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):260-8. doi: 10.1016/j.ijrobp.2009.06.043. Epub .

PMID:
19879698
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk